Course #1 - Study Director Training All Day

COURSE #1 - STUDY DIRECTOR TRAINING – ALL DAY Chair: Barbara J. Mounho, Ph.D., DABT, Toxicologist Research Scientist, Amgen Inc., Thousand Oaks, CA

COURSE #2 - RISK ASSESSMENT: CURRENT PRACTICES AND FUTURE DIRECTIONS – ALL DAY Chair: Annette M. Shipp, Ph.D., Principal, ENVIRON International Corporation, Ruston, LA

COURSE #3 - CARDIOVASCULAR ASSESSMENT: THE PRECEDING, CONTEMPORARY AND PROSPECTIVE VIEWPOINT Co-Chairs: Alfred N. Botchway, Ph.D., President, Xenometrics, LLC, Stilwell, KS and Elaine V. Knight, Ph.D., Research Fellow, Johnson & Johnson Pharmaceutical Research & Development, LLC, Raritan, NJ

COURSE #4 - RESPIRATORY DRUG DEVELOPMENT - A REVIEW OF CURRENT KNOWLEDGE Chair: Norman Kim, M.S., DABT, Inotek Pharmaceuticals Corporation, Beverly, MA

COURSE #5 - APPLICATION OF THE HUMAN RELEVANCE FRAMEWORK TO THE ANALYSIS OF RODENT TUMOR DATA Co-Chairs: Jerry F. Hardisty, DVM, DACVP, Fellow IATP, President/Veterinary Pathologist, EPL Inc., Research Triangle Park, NC and Douglas C. Wolf, DVM, Ph.D., Fellow IATP, Staff Scientist, US EPA, Environmental Carcinogenesis Division, Natl Health & Environmental Effects Research Laboratory, Research Triangle Park, NC

COURSE #6 - SCREENING FOR DRUG ABUSE POTENTIAL: GUIDELINES AND EXPECTATIONS Chair: Gene E. Schulze, Ph.D., DABT, Group Director, Dept. of Toxicology, Bristol-Myers Squibb Company, Syracuse, NY

SYMPOSIUM I - WHAT YOU ALWAYS WANTED TO KNOW ABOUT REACH; BUT WERE AFRAID TO ASK Co-Chairs: James C. Lamb, IV, Ph.D., DABT, Senior Vice President, The Weinberg Group, Washington DC and Michael Holsapple, Ph.D., ATS, Executive Director, ILSI / HESA, Washington, DC

SYMPOSIUM II - INHALATION TOXICOLOGY: TECHNOLOGICAL AND REGULATORY TIPS OF THE TRADE Co-Chairs: Hilary Sheevers, Ph.D., President, CEO, Aclairo Pharmaceutical Development Group, Inc., Vienna, VA and Theresa Sweeney, Ph.D., Director Life Sciences, Nektar Therapeutics, San Carlos, CA

SYMPOSIUM III - USE OF NON-MAMMALS FOR TOXICOLOGICAL AND DRUG DISCOVERY STUDIES Chair: Michael Ashner, Ph.D., Professor, Vanderbilt University Medical Center, Nashville, IL SYMPOSIUM IV - COMBINATION TOXICOLOGY Co-Chairs: Melissa Rhodes, Ph.D., Project Manager, Safety Assessment, GlaxoSmithKline, Research Triangle Park, NC and Michael Wyde, Ph.D., DABT, Toxicologist, NTP, Research Triangle Park, NC

SYMPOSIUM V- BUILDING COMPREHENSIVE IN VITRO SCREENING APPROACHES FOR PREDICTING ANIMAL AND HUMAN TOXICITY: IMPROVING THE DRUG SELECTION PROCESS Co-Chairs: James M. McKim, IV, Ph.D., DABT, President/CEO, CeeTox, Inc., Kalamazoo, MI and Edward LeCluyse, Ph.D., Chief Scientific Officer, CellzDirect, Pittsboro, NC

SYMPOSIUM VI - THE IMPACT OF IMMUNOTOXICITY ON MOVING PHARMACEUTICAL PRODUCTS THROUGH CLINICAL DEVELOPMENT Co-Chairs: Marque D. Todd, DVM, DABT, Principal Scientist, Amgen Inc., Thousand Oaks, CA and Barbara Mounho, Ph.D., DABT, Principal Scientist, Amgen Inc., Thousand Oaks, CA

SYMPOSIUM VII - SAFETY PHARMACOLOGY Co-Chairs: Stephen Wilson , Scientist I, Safety Sciences, Charles River Laboratories, Worcester, MA and Kenneth J. Olivier Jr., Ph.D., Project Manager/Investigative Toxicologist, GlaxoSmithKline, Research Triangle Park, NC

SYMPOSIUM VIII - PEDIATRIC INITIATIVES AND CONCERNS Co-Chairs: Mildred S. Christian, Ph.D., Fellow, ATS, President, Argus International, Inc., Horsham, PA and Alan B. Hoberman, Ph.D., Fellow, ATS, DABT, General Manager, Charles River Laboratories - PA, Horsham, PA

SYMPOSIUM IX - SMOKING AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: STATE OF KNOWLEDGE AND FUTURE DISCUSSIONS Co-Chairs: Willie J. McKinney, Ph.D., DABT, Principal Scientist, Philip Morris USA, Richmond, VA and Chris Coggins, Ph.D., DABT, Consultant, Carson Watts Consulting, King, NC

SYMPOSIUM X - CURRENT TRENDS AND ADVANCEMENT IN ENVIRONMENTAL CHEMICAL RISK ASSESSMENT Co-Chairs: Richard Phillips, ExxonMobil Petroleum & Chemical, Machelen, Belgium and Richard A. Becker, American Chemistry Council, Arlington, VA

SYMPOSIUM XI - DERMAL ABSORPTION: AN IMPORTANT CONSIDERATION FOR RISK ASSESSMENT - MODELS AND THEIR APPLICATIONS Co-Chairs: Jon F. Lalko, B.S., Senior Program Specialist, Human Health, RIFM, Inc. Woodcliff Lake, NJ and Daniel Isola, Newburgh, NY

SYMPOSIUM XII - TOXICOLOGIC CONSIDERATIONS IN THE TREATMENT OF OBESITY Chair: Tracey Zoetis, M.S., Managing Consultant, SciLucent, LLC, Herndon, VA SYMPOSIUM XIII - STRESS AS A CONFOUNDING FACTOR IN THE CONDUCT AND INTERPRETATION OF TOXICOLOGICAL STUDIES Co-Chairs: Jerry F. Hardisty, DVM, DACVP, President, EPL, Inc., Research Triangle Park, NC and L.D. Hopper, DVM, Ph.D., DABT, Director of Toxicology, BASi, Mount Vernon, IN

SYMPOSIUM XIV - REPRODUCTIVE AND DEVELOPMENTAL RISK ASSESSMENT FOR BIOLOGICS IN THE NONHUMAN PRIMATE MODEL: WHEN AND HOW SHOULD STUDIES BE CONDUCTED? Co-Chairs: Gerhard Weinbauer, Ph.D., Director, Research and Safety Assessment, Covance Laboratories GmbH, Muenster, Germany and Barbara J. Mounho, Ph.D., DABT, Principal Scientist, Amgen Inc., Thousand Oaks, CA

SYMPOSIUM XV - EXPERIENCES WITH MICRODOSING TRIALS Co-Chairs: Melissa Rhodes, Ph.D., Project Manager, Safety Assessment, GlaxoSmithKline, Research Triangle Park, NC and Colin Garner, Bpharm, Ph.D., D.Sc., FRCPath, Founder and CEO, Xceleron Inc., Heslington, UK

SYMPOSIUM XVI - SAFETY EVALUATION OF OCULAR DRUGS FOR RETINAL DISEASES: FOCUS ON STRATEGIES AND PRACTICAL APPROACHES Co-Chairs: Brian Short, VDM, Ph.D., DACVP, Senior Director, Pathology, Allergan, Inc., Irvine, CA and Andrea Weir, Ph.D., DABT, Senior Scientific Advisor, Charles River Laboratories, Navigators, Sparks, NV

SYMPOSIUM XVII - HOT TOPICS IN DRUG DEVELOPMENT Co-Chairs: Drew Badger, Ph.D., DABT, Director, Discovery Toxicology and Scientific Operations, Allergan, Inc., Irvine, CA and Mary Ellen Cosenza, Ph.D., DABT, RAC, Executive Director, Regulatory Affairs, Amgen Inc., Thousand Oaks, CA

SYMPOSIUM XVIII - CONDUCTING NONCLINICAL TOXICOLOGY STUDIES IN CHINA: OPPORTUNITIES, ISSUES, AND CONCERNS Co-Chairs: Vincent L. Reynolds, Ph.D., DABT, Principal Research Toxicologist, Eli Lilly and Company, Greenfield, IN and William Chen, Ph.D., DABT, Professor, China Agricultural University, Beijing, PRC